Strepsils with menthol and eucalyptus, 1.2 mg + 0.6 mg, hard lozenges
Alcohol 2,4–dichlorobenzylicus + Amylmetacresolum
This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist.
Strepsils with menthol and eucalyptus contains:
Strepsils with menthol and eucalyptus is intended for symptomatic treatment of inflammatory conditions of the mouth and throat.
Before taking Strepsils with menthol and eucalyptus, the patient should discuss it with their doctor if they have:
No clinically significant interactions of Strepsils with menthol and eucalyptus with other medicines are known.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
The effect of the medicine on the ability to drive and use machines is not known.
If the patient has previously been diagnosed with intolerance to some sugars, they should consult their doctor before taking the medicine. The medicine contains 1.496 g of sucrose and 1.013 g of glucose per hard lozenge. This should be taken into account in patients with diabetes.
This medicine contains very small amounts of gluten (from wheat starch present in glucose syrup) and is considered "gluten-free". It is therefore very unlikely to cause any problems in patients with coeliac disease. One hard lozenge contains no more than 20.26 micrograms of gluten. Patients with an allergy to wheat (other than coeliac disease) should not take this medicine.
Due to the trace amounts of sulfur dioxide (E 220) from glucose syrup, this medicine may rarely cause severe hypersensitivity reactions and bronchospasm.
Indigotine contains trace amounts of sodium. The medicine contains less than 1 mmol (23 mg) of sodium per hard lozenge, which means that the medicine is considered "sodium-free".
The medicine contains a fragrant substance with d-limonene. D-limonene may cause allergic reactions.
This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist. If in doubt, the patient should consult their doctor or pharmacist. For use on the mucous membrane of the mouth. Adults and children over 6 years of age: suck slowly one lozenge every 2-3 hours. The patient should use the smallest effective dose for the shortest duration necessary to relieve symptoms. The dose should not exceed 8 lozenges per day. If symptoms persist or worsen after 3 days, the patient should consult their doctor.
Overdose is unlikely to cause any symptoms other than gastrointestinal disturbances. Symptomatic treatment should be applied.
The patient should not take a double dose to make up for a missed lozenge. If the patient has any further doubts about taking this medicine, they should consult their doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Frequency not known(frequency cannot be estimated from the available data)
Reporting side effects
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should inform their doctor or pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Aleje Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309,
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
Store in a temperature below 25°C.
The medicine should be stored out of sight and reach of children.
Do not take this medicine after the expiry date stated on the packaging after: EXP.
The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Blue, round hard lozenge.
The packaging contains 8, 12, 24, 32, or 36 hard lozenges.
Not all pack sizes may be marketed.
Reckitt Benckiser (Poland) S.A.
ul. Okunin 1
RB NL Brands B.V.
WTC Schiphol Airport,
Schiphol Boulevard 207,
1118 BH Schiphol,
Netherlands
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.